am 251 and carbachol
am 251 has been researched along with carbachol in 8 studies
Research
Studies (8)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (37.50) | 29.6817 |
2010's | 5 (62.50) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Alger, BE; Isokawa, M; Kim, J; Ledent, C | 1 |
Boxberger, M; Choritz, L; Krauss, A; Meissner, S; Rosenthal, R; Stumpff, F; Thieme, H; Wiederholt, M | 1 |
Alger, BE; Jones, LM; Karnup, SV; Karson, MA; Reich, CG | 1 |
Haghparast, A; Hassanpour-Ezatti, M; Safari, MS; Taslimi, Z | 1 |
Lograno, MD; Romano, MR | 1 |
Haghparast, A; Jahangirvand, M; Moradi, M; Pirasteh, AH; Yazdi, F | 1 |
Esmaeili, MH; Ezzatpanah, S; Haghparast, A; Reisi, Z | 2 |
Other Studies
8 other study(ies) available for am 251 and carbachol
Article | Year |
---|---|
Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus.
Topics: Animals; Calcium; Cannabinoid Receptor Modulators; Cannabinoids; Carbachol; Cholinergic Agonists; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Evoked Potentials; GTP-Binding Proteins; Hippocampus; In Vitro Techniques; Interneurons; Male; Mice; Mice, Knockout; Neural Inhibition; Patch-Clamp Techniques; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug; Receptors, Metabotropic Glutamate; Receptors, Muscarinic | 2002 |
Stimulation of cannabinoid (CB1) and prostanoid (EP2) receptors opens BKCa channels and relaxes ocular trabecular meshwork.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; 8-Bromo Cyclic Adenosine Monophosphate; Adult; Aged; Animals; Benzoxazines; Calcium; Calcium Channel Blockers; Cannabinoids; Carbachol; Cattle; Cells, Cultured; Cholinergic Agonists; Cyclic AMP; Cyclohexanols; Endothelin-1; Humans; In Vitro Techniques; Ion Channel Gating; Middle Aged; Morpholines; Naphthalenes; Patch-Clamp Techniques; Peptides; Piperidines; Potassium Channels, Calcium-Activated; Prostanoic Acids; Pyrazoles; Receptor, Cannabinoid, CB1; Receptors, Prostaglandin E; Stimulation, Chemical; Trabecular Meshwork | 2005 |
Regulation of IPSP theta rhythm by muscarinic receptors and endocannabinoids in hippocampus.
Topics: Action Potentials; Amino Acids; Animals; Cannabinoid Receptor Modulators; Carbachol; Cholinergic Agonists; Endocannabinoids; Excitatory Amino Acid Antagonists; Hippocampus; In Vitro Techniques; Male; Methoxyhydroxyphenylglycol; Neural Inhibition; Piperidines; Pyrazoles; Quinoxalines; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Spectrum Analysis; Synapses; Theta Rhythm; Time Factors; Xanthenes | 2005 |
Chemical stimulation of the lateral hypothalamus induces conditioned place preference in rats: Involvement of OX1 and CB1 receptors in the ventral tegmental area.
Topics: Animals; Benzoxazoles; Carbachol; Choice Behavior; Conditioning, Operant; Dose-Response Relationship, Drug; Hypothalamic Area, Lateral; Male; Naphthyridines; Neural Pathways; Orexin Receptors; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor Cross-Talk; Receptor, Cannabinoid, CB1; Receptors, G-Protein-Coupled; Receptors, Neuropeptide; Reward; Urea; Ventral Tegmental Area | 2011 |
Signaling cross-talk between cannabinoid and muscarinic systems actives Rho-kinase and increases the contractile responses of the bovine ciliary muscle.
Topics: Animals; Arachidonic Acids; Cannabinoid Receptor Agonists; Cannabinoid Receptor Antagonists; Carbachol; Cattle; Cholinergic Agonists; Ciliary Body; Endocannabinoids; In Vitro Techniques; Muscarinic Antagonists; Muscle Contraction; Muscle, Smooth; Piperidines; Polyunsaturated Alkamides; Protein Kinase C; Pyrazoles; Receptor, Cannabinoid, CB1; Receptor, Muscarinic M3; rho-Associated Kinases | 2013 |
Functional interaction between OX2 and CB1 receptors in the ventral tegmental area and the nucleus accumbens in response to place preference induced by chemical stimulation of the lateral hypothalamus.
Topics: Animals; Carbachol; Conditioning, Psychological; Dose-Response Relationship, Drug; Drug Synergism; Hypothalamic Area, Lateral; Isoquinolines; Male; Microinjections; Nucleus Accumbens; Orexin Receptor Antagonists; Orexin Receptors; Piperidines; Pyrazoles; Pyridines; Rats; Receptor, Cannabinoid, CB1; Reward; Stimulation, Chemical; Ventral Tegmental Area | 2015 |
Functional interaction between orexin-1 and CB1 receptors in the periaqueductal gray matter during antinociception induced by chemical stimulation of the lateral hypothalamus in rats.
Topics: Animals; Benzoxazoles; Carbachol; Disease Models, Animal; Hypothalamic Area, Lateral; Male; Microinjections; Naphthyridines; Orexin Receptors; Orexins; Pain; Pain Measurement; Periaqueductal Gray; Piperidines; Pyrazoles; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Stimulation, Chemical; Urea | 2016 |
Role of orexin-2 and CB1 receptors within the periaqueductal gray matter in lateral hypothalamic-induced antinociception in rats.
Topics: Animals; Carbachol; Disease Models, Animal; Dose-Response Relationship, Drug; Hypothalamic Area, Lateral; Isoquinolines; Male; Orexin Receptor Antagonists; Orexin Receptors; Orexins; Pain; Periaqueductal Gray; Piperidines; Pyrazoles; Pyridines; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1 | 2017 |